Pfizer's Dividend Faces Big Questions. Here Are 3 Reasons It Should Survive.
Key PointsPfizer's management remains firmly committed to maintaining the dividend.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.